1999
DOI: 10.1016/s0022-3468(99)90168-9
|View full text |Cite
|
Sign up to set email alerts
|

Long-term follow-up of nineteen cystic lymphangiomas treated with fibrin sealant

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
2

Citation Types

0
23
0

Year Published

2002
2002
2023
2023

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 48 publications
(23 citation statements)
references
References 13 publications
0
23
0
Order By: Relevance
“…Another limit of OK-432 is the risk of an adverse reaction in patients with a penicillin G allergy and difficulties in acquiring the substance. In 1991, Castañon et al [31] noted that injection of fibrin glue (Tissucol) inside the lymphatic cyst was followed by adhesion of the cystic surfaces. Recently, an alcoholic solution of zein (Ethibloc) has been proposed as a sclerosing agent for lymphatic malformations.…”
Section: Discussionmentioning
confidence: 99%
“…Another limit of OK-432 is the risk of an adverse reaction in patients with a penicillin G allergy and difficulties in acquiring the substance. In 1991, Castañon et al [31] noted that injection of fibrin glue (Tissucol) inside the lymphatic cyst was followed by adhesion of the cystic surfaces. Recently, an alcoholic solution of zein (Ethibloc) has been proposed as a sclerosing agent for lymphatic malformations.…”
Section: Discussionmentioning
confidence: 99%
“…Simple puncture, irradiation, and chemotherapy have been tried and abandoned. Intracystic injection of sclerosing agents has been used in recent years [6,[11][12][13][14][15][16][17][18][19]. The main substances used were bleomycin, doxycyclin, OK-432, Fibrin sealant, and Ethibloc.…”
Section: Discussionmentioning
confidence: 99%
“…This confirms the historical results achieved by most major surgical centers and the reasons why alternative methods are sought. In most pediatric centers surgical excision, either partial or complete, has been replaced by alternative non-surgical methods of management, i.e., sclerosing therapy with bleomycin, 0K432 and others [11][12][13][14]. We, however, do not have experience with this treatment modality at the moment but plans for a trial are underway.…”
Section: Discussionmentioning
confidence: 99%